Pfizer Inc. is renewing its partnership with the Union for International Cancer Control through a grant of $530,000 for the Seeding Progress and Resources for the Cancer Community: Metastatic Breast Cancer Challenge. Read More »

Bristol-Myers Squibb Co. and Pfizer Inc. will present eight of their abstracts at the American College of Cardiology's 66th Annual Scientific Session in Washington, D.C. March 17-19. Read More »

Merck, which is known as MSD outside the United States and Canada, and Pfizer Inc. recently announced the acceptance for review of three New Drug Applications by the U.S. Food and Drug Administration. Read More »

McKesson Health Solutions, a company that specializes in helping patients with medical payments, recently announced its new analytics system HealthQx received certification in the Prometheus Analytics model. Read More »

CBI's Formulary, Co-Pay and Access Summit will convene April 11-12 to address patient affordability barriers and more.  Read More »

Pfizer Inc. has partnered with relationship expert Logan Levkoff to host a Q&A session on relationship and intimacy advice for people dealing with chronic diseases.  Read More »

Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »

Dealing with the thorny, and often contentious, issue of drug prices is likely to be front and center in the early days of the new Trump administration. Arriving at a solution to curb increasing costs will be a delicate balance for all those with a stake in the issue, according to a leading health economist. Read More »

RxWiki Inc. has launched Patient Verified Reviews, a platform that allows patients to rate their pharmacy. Read More »

McKesson and Health Mart support the dedication of pharmacists across all practice settings and commend the American Pharmacists Association for celebrating pharmacists’ commitment to provide customers with extraordinary service. Read More »

Alcon, a worldwide leader in eye care and a Novartis division, has released its Online Toric IOL Calculator, which was developed for the use of cataract surgeons who are treating patients with corneal astigmatism. Read More »

Alcon, a division of Novartis that specializes in eye care, has received approval from the U.S. Food and Drug Administration for AcrySof IQ ReSTOR +3.0D Multifocal Toric Intraocular Lens (IOL), which was developed to treat presbyopia and pre-existing corneal astigmatism. Read More »

Pfizer will expand its Advancing Science through Pfizer Investigator Research Exchange program next year. Read More »

Pfizer and its partner Avillion LLP have announced the results from the BFORE clinical study. Read More »

Pfizer's executive vice president and president of global supply Anthony Maddaluna is retiring after 41 years with the company. Read More »

McKesson Specialty Health hosted its two-day 2016 Onmark Fall Leadership Summit in Orlando, Florida, featuring the possible transformation that community oncology practices are having to make so they can survive in the ever-evolving world of care based on value and payment reform. Read More »

Pfizer has released data from its Phase 1b clinical trial involving INLYTA, which has been combined with pembrolizumab, a PD-1 checkpoint inhibitor known as KEYTRUDA, in patients who have advanced renal cell carcinoma (RCC) that have yet to undergo treatment. Read More »

Pfizer has released results from its Phase 3 S-TRAC clinical study involving the assessment of SUTENT as an adjuvant therapy. Read More »

Pfizer has released data from its Phase 1b INLYTA clinical trial in which the drug is combined with pembrolizumab, a PD-1 inhibitor called KEYTRUDA, and marketed by Merck. Read More »

Abbott announced this week that its FreeStyle Libre Pro system, a groundbreaking continuous glucose monitoring (CGM) system designed for patients with diabetes, has been approved by the U.S. Food and Drug Administration (FDA).re Read More »